Drugs Health Pharma

J&J halts final phase of trials of a drug to treat hypertension, says “futile” 

HQ Team September 7, 2023: Johnson & Johnson has decided to halt an experimental trial, in its final stages, on a drug to.

Read More
Drugs Pharma

Johnson & Johnson pulls out of HIV phase III trial

Johnson & Johnson stopped the phase III trial of its global HIV vaccine trial after it found that the regimen was ineffective in.

Read More
Medical

Hetero buys J&J’s manufacturing site in India

HQ Team October 18, 2022: Hetero, an Indian pharmaceutical company, announced the acquisition of a brownfield manufacturing plant of Johnson & Johnson Private.

Read More